Sarki A. Abdulkadir, MD, PhD, discusses the challenges of targeting MYC in prostate cancer.
Sarki A. Abdulkadir, MD, PhD
Advertisement
Articles by Sarki A. Abdulkadir, MD, PhD
Sarki A. Abdulkadir, MD, PhD, discusses the rationale to target MYC in prostate cancer.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Iberdomide Plus Daratumumab/Dexamethasone for R/R Myeloma
2
Dr Banerjee on the FDA Approval of Iberdomide Plus Daratumumab/Dexamethasone in R/R Myeloma
3
Dr Carlino on 5-Year Data With Intismeran Plus Pembrolizumab in Resected Melanoma
4
Dr Garg on a Phase 3 Study of Proton Therapy in Head and Neck Cancer
5